There are often no symptoms with cervical dysplasia. Cervical changes are most often found in screening tests.
Cervical dysplasia is often found as part of regular screening. A pap tests takes a sample of cervix cells. The sample is sent to a lab for testing. After a pap test cervical dysplasia may be diagnosed as:
ASCUS (atypical squamos cells of undetermined significance)—Can be caused common issues such as infections, cysts, polyps, or hormonal changes.
LSIL (low-grade squamos intra-epithelial lesion)—Changes are mild and often caused by HPV infection.
HSIL (high-grade squamos intra-epithelial lesion)—Caused by HPV and can become cervical cancer.
ASCH (atypical squamos cells)—May be HSIL. Will need more testing.
AGC (atypical glandular cells)—May be cancer or precancer.
AIS (adenocarcinoma in situ)—Advanced changes with high risk of becoming cancer.
A colposcopy and biopsy may be done after abnormal Pap test. A small sample of abnormal cells will be removed and tested at a lab. It will help to get more information on cell changes.
Testing for HPV may also be done since it is a common cause of cervical dysplasia.
pap test screening will be done more often after abnormal results.
Treatment will vary based on type, location, and area that is affected. Some dysplasia does not need treatment or will go away on its own. Regular pap tests will be done to track changes.
Cervical dysplasia that increases the risk for cancer will be treated. The goal of treatment is to destroy or remove abnormal cells. Options include:
Cone biopsy—a cone-shaped area of tissue is removed. It should remove all abnormal cells.
LEEP—a wire loop is used to remove abnormal tissue.
Cryosurgery—abnormal tissue is destroyed with cold. Can only be used for smaller areas of dysplasia.
Laser Treatment—high-energy beam of light is used to destroy abnormal cells. It tends to cause less damage to nearby healthy tissue than cryosurgery. Laser is not always available.
Lifestyle changes may lower the risk of cervical dysplasia.
Use safe sex steps to prevent HPV infection. Condom is one choice.
American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol. 2016 Jan;127(1):e1.
Cervical cancer screening. EBSCO DynaMed website. Available at: http://www.dynamed.com/topics/dmp~AN~T116761/Cervical-cancer-screening. Accessed March 9, 2021.
Immunization schedules. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/vaccines/schedules/index.html. Accessed March 9, 2021.
Management of Abnormal Cervical Cytology. EBSCO DynaMed website. Available at: https://www.dynamed.com/management/management-of-abnormal-cervical-cytology. Accessed March 9, 2021.
Massad LS, Einstein MH, Huh WK, et al; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.